- How deep is LDL cholesterol fall?2014 | First Faculty of Medicine
- Regulation of intracellular metabolism of LDL-cholesterol: the importance of inhibition of PCSK92014 | Faculty of Medicine in Hradec Králové
- Evolocumab: lowering of both the LDL cholesterol and cardiovascular risk2015 | First Faculty of Medicine
- Very low LDL cholesterol in acute coronary syndrome2020 | Second Faculty of Medicine
- High prevalence of cadriovascular risk factors and inadequiate control of LDL cholesterol levels in the population of 40-year old men and 50-year old women in the Czech Republic2016 | First Faculty of Medicine
- The reason for the statin drop after extracorporeal LDL-cholesterol elimination in familial hypercholesterolemia2010 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Why not to interfere with LDL-cholesterol freefall and why not to talk badly about statins2018 | Second Faculty of Medicine
- How to deal ugly twins, LDL-cholesterol and lipoprotein (a)2016 | Second Faculty of Medicine
- How to increase HDL and decrease LDL-cholesterol?2012 | First Faculty of Medicine
- LDL - cholesterol2006 | Publication without faculty affiliation
- LDL-cholesterol: the lower the better! We need a new lipid lowering drugs? Focus on alirokumab (Praluent)2015 | First Faculty of Medicine
- Effects of the LDL cholesterol lowering in patients in chronic kidney disease. SHARP study. Commentary.2011 | First Faculty of Medicine
- Extracorporeal LDL-cholesterol elimination (25 years of experience in CZ)2009 | Faculty of Medicine in Hradec Králové
- Intensive reduction of LDL cholesterol and ezetimibe for the treatment of evidence2009 | First Faculty of Medicine
- Plant sterols and stanols: not yet own recommendations for diet enrichment targeted reduction of LDL - cholesterol and cardiovascular risk2015 | First Faculty of Medicine
- Use of ultra high performance liquid chromatography-tandem mass spectrometry to demonstrate decreased serum statin levels after extracorporeal LDL-cholesterol elimination2011 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Treatment to reduce concentration LDL cholesterol - from atorvastatin to ezetimibe2018 | First Faculty of Medicine
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial2011 | First Faculty of Medicine
- Side effects and complications of extracorporeal elimination of LDL-cholesterolPublication without faculty affiliation
- Significance of non-invasive cardiovascular examinations for the evaluation of extracorporeal LDL-cholesterol elimination efficacy2007 | Publication without faculty affiliation
- Significance of non-invasive cardiovascular examinations for the evaluation of extracorporeal LDL-cholesterol elimination efficacy +12007 | Faculty of Medicine in Hradec Králové
- Significance of non-invasive cardiovascular examinations for the evaluation of extracorporeal LDL-cholesterol elimination efficacy2007 | First Faculty of Medicine
- Do we use statins enough? News in the combination treatment by statins and ezetimibe2016 | Faculty of Medicine in Pilsen
- The 95th percentile of LDL-cholesterol in the Czech population: The Czech post- MONICA study2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Commentary to the new analysis of IMPROVE-IT study concerning achievment of dual goals LDL-cholesterol nad C reactive protein2015 | Faculty of Medicine in Pilsen
- The treatment of hypercholesterolemia by PCSK9 inhibitors2014 | Faculty of Medicine in Hradec Králové
- Monoclonal antibodies in the treatment of dyslipidemia and cardiovascular risk reduction2015 | First Faculty of Medicine
- LDL-apheresis and other methods of extracorporeal LDL-cholesterol elimination2004 | Faculty of Medicine in Hradec Králové
- Inhibitors PCSK9 - experience after two years of practice in the Czech Republic2017 | Faculty of Medicine in Hradec Králové